Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Alphavase 1 tablets
0205040S0BEABAC
|
Alphavase | Prazosin hydrochloride | Cardiovascular System | No data available |
|
Alphavase 2 tablets
0205040S0BEACAD
|
Alphavase | Prazosin hydrochloride | Cardiovascular System | No data available |
|
Alphavase 5 tablets
0205040S0BEADAE
|
Alphavase | Prazosin hydrochloride | Cardiovascular System | No data available |
|
Alteplase 10mg inj vials
0210020V0AAAAAA
|
Alteplase | Alteplase | Cardiovascular System | No data available |
|
Alteplase 20mg inj vials
0210020V0AAABAB
|
Alteplase | Alteplase | Cardiovascular System | No data available |
|
Alteplase 2mg inj vials
0210020V0AAADAD
|
Alteplase | Alteplase | Cardiovascular System | No data available |
|
Alteplase 2mg powder for solution for injection vials
0210020V0AAAEAE
|
Alteplase | Alteplase | Cardiovascular System | No data available |
|
Alteplase 50mg inf vials
0210020V0AAACAC
|
Alteplase | Alteplase | Cardiovascular System | No data available |
|
Ambrisentan 10mg tablets
0205010X0AAABAB
|
Ambrisentan | Ambrisentan | Cardiovascular System | No data available |
|
Ambrisentan 2.5mg tablets
0205010X0AAACAC
|
Ambrisentan | Ambrisentan | Cardiovascular System | No data available |
|
Amil-Co 5mg/50mg tablets
0202040C0BBAAAA
|
Amil-Co | Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | Cardiovascular System | No data available |
|
Amilamont 5mg/5ml oral solution sugar free
0202030C0BFAAAS
|
Amilamont | Amiloride hydrochloride | Cardiovascular System | No data available |
|
Amilmaxco 5mg/50mg tablets
0202040C0BGAAAA
|
Amilmaxco | Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | Cardiovascular System | No data available |
|
Amiloride 1.5mg/5ml oral liquid
0202030C0AAA8A8
|
Amiloride hydrochloride | Amiloride hydrochloride | Cardiovascular System | No data available |
|
Amiloride 1.7mg/5ml oral liquid
0202030C0AABBBB
|
Amiloride hydrochloride | Amiloride hydrochloride | Cardiovascular System | No data available |
|
Amiloride 10mg/5ml / Furosemide 125mg/5ml oral liquid
0202040B0AAALAL
|
Co-amilofruse | Co-amilofruse (Amiloride hydrochloride/frusemide) | Cardiovascular System | No data available |
|
Amiloride 10mg/5ml oral liquid
0202030C0AAAZAZ
|
Amiloride hydrochloride | Amiloride hydrochloride | Cardiovascular System | No data available |
|
Amiloride 12.5mg/5ml oral liquid
0202030C0AABABA
|
Amiloride hydrochloride | Amiloride hydrochloride | Cardiovascular System | No data available |
|
Amiloride 1mg/5ml oral liquid
0202030C0AAA1A1
|
Amiloride hydrochloride | Amiloride hydrochloride | Cardiovascular System | No data available |
|
Amiloride 2.3mg/5ml oral liquid
0202030C0AABEBE
|
Amiloride hydrochloride | Amiloride hydrochloride | Cardiovascular System | No data available |
|
Amiloride 2.5mg / Cyclopenthiazide 250microgram tablets
0202040A0AAAAAA
|
Amiloride hydrochloride/cyclopenthiazide | Amiloride hydrochloride with thiazides | Cardiovascular System | No data available |
|
Amiloride 2.5mg/5ml oral liquid
0202030C0AAA4A4
|
Amiloride hydrochloride | Amiloride hydrochloride | Cardiovascular System | No data available |
|
Amiloride 2mg/5ml oral liquid
0202030C0AAA6A6
|
Amiloride hydrochloride | Amiloride hydrochloride | Cardiovascular System | No data available |
|
Amiloride 300micrograms/5ml oral liquid
0202030C0AAA5A5
|
Amiloride hydrochloride | Amiloride hydrochloride | Cardiovascular System | No data available |
|
Amiloride 3mg/5ml oral liquid
0202030C0AAA2A2
|
Amiloride hydrochloride | Amiloride hydrochloride | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.